Chemical Name: 1-(5-Deoxy-β-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-dione (as per EP); 5′-Deoxy-5-fluorouridine (as per USP)
Synonym: Capecitabine USP related compound B ; 5-Fluoro-5'-deoxyuridine
Smiles: CC1C(C(O)[C@H](N2C(NC(C(F)=C2)=O)=O)O1)O
Inchi: InChI=1S/C9H12FN3O4/c1-3-5(14)6(15)8(17-3)13-2-4(10)7(11)12-9(13)16/h2-3,5-6,8,14-15H,1H3,(H2,11,12,16)/t3-,5-,6-,8-/m1/s1
Design of experiments (DoE) - based enhanced quality by design approach to hydrolytic degradation kinetic study of capecitabine by eco-friendly stability indicating UV-visible spectrophotometry
By Prajapati, Pintu; Patel, Radhika; Patel, Dilan; Shah, Shailesh
From American Journal of PharmTech Research (2020), 10(6), 115-133
Validated stability indicating HPLC method for estimation of capecitabine
By Lalitha, K. V.; Raveendra Reddy, J.; Devanna, N.
From International Journal of Pharmaceutical Sciences and Research (2020), 11(11), 5651-5658
RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.
From International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67